Simvastatin plus capecitabine-cisplatin (XP) versus placebo plus capecitabine-cisplatin (XP) in patients with previously untreated advanced gastric cancer: A double-blind randomized phase 3 study
- All Author(s)
- S. Kim
; W. K. Kang
; J. Lee
; S. H. Park
; J. O. Park
; Y. S. Park
; H. Y. Lim
; J. H. Kang
; I. G. Hwang
; S. C. Lee
; K. W. Park
; H. R. Lee
- Intsitutional Author(s)
- 이상철
- Issued Date
- 2014
- Type
- Conference
- Conference Name
- 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
- Conference Date
- 41789
- dc_citation_conferenceCountry
- Chicago, IL, United States
- Citation Publisher
- American Society of Clinical Oncology
- Citation Title
- Journal of Clinical Oncology. Volume 32, Number 15_suppl
- Citation Start Page
- 4066
- Citation End Page
- 4066
- Language(ISO)
- eng
- DOI
- 10.1200/jco.2014.32.15_suppl.4066
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/4538
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.